AI in Drug Discovery

Description

Artificial intelligence is not limited to software or text generators; it is also reshaping the future of biomechanics, life sciences, and pharmacology. Modern AI models accelerate the synthesis and analysis of millions of molecules, reducing the drug discovery timeline from years to days. In the next meetup of GDG Baku, we will take an in-depth look at this exciting field where science and technology intersect.🎙 Serkhan Badirli, Partner and CTO of Glacies Biome, former Senior AI Researcher at Eli Lilly (for small-molecule discovery), PhD graduate in Computer Science from Purdue University. Serkhan Badirli is a world-class researcher with extensive experience in machine learning (ML), particularly in the fields of drug discovery and biomechanics. He has worked on AI-based molecular design at the global giant Eli Lilly and is currently applying AI technologies to biology at Glacies Biome.📅 22.08.2026🕚 11:00📍 LTC, Maria Curie (Caspian Plaza, 18th floor)